✦ LIBER ✦

Results of a phase II study of liposomal doxorubicin (Myocet®) in combination with weekly paclitaxel and trastuzumab (Herceptin®) In patients with HER2-positive locally advanced or metastatic breast cancer (LA/MBC)

✍ Scribed by J Baselga; M.A Climent; A Lluch; J Hornedo; P Gascon; A.T Sanchez; V Guillem; H Cortés-Funes; P Regueiro; J Trigo

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase III trial of nonpegylated liposoma

✍ Baselga, J.; Manikhas, A.; Cortes, J.; Llombart, A.; Roman, L.; Semiglazov, V. F 📂 Article 📅 2014 🏛 Oxford University Press 🌐 English ⚖ 273 KB

A Phase II Study of Weekly Vinorelbine a

✍ Juan Lucas Bayo-Calero; José I. Mayordomo; Pedro Sánchez-Rovira; Ramón Pérez-Car 📂 Article 📅 2008 🏛 CIG Media Group, LP. 🌐 English ⚖ 97 KB

Efficacy and safety of three-weekly herc

✍ S. Verma; B. Leyland-Jones; J.-P. Ayoub; K. Gelmon; A. Arnold; C. Szakacs; J. Ho 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 173 KB

Phase II Study of Weekly Docetaxel Alone

✍ Joshua P. Raff; Lakshmi Rajdev; Umekalsoom Malik; Yelena Novik; Jane M. Manalo; 📂 Article 📅 2004 🏛 CIG Media Group, LP. 🌐 English ⚖ 126 KB

A phase I/II trial of non-pegylated lipo

✍ D. Amadori; C. Milandri; G. Comella; S. Saracchini; S. Salvagni; C. Barone; R. B 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 226 KB

A phase II study of bevacizumab in combi

✍ Lin, N. U.; Seah, D. S.; Gelman, R.; Desantis, S.; Mayer, E. L.; Isakoff, S.; Di 📂 Article 📅 2013 🏛 Springer US 🌐 English ⚖ 258 KB